Immunome Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Immunome Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Immunome Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 60.4M shares, a 395% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 60.4M +48.2M +395% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 60M +47.8M +392% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 59.7M +47.5M +390% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 43.3M +31.1M +257% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 12.2M +74.9K +0.62% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 12.2M +73K +0.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 12.2M +66.8K +0.55% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 12.1M +18.5K +0.15% Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.1M +34.3K +0.28% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 12.1M +315K +2.66% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 12.1M +1.47M +13.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 12.1M +1.48M +13.9% Dec 31, 2021 10-K 2023-03-16
Q3 2021 12.1M +11M +975% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 11.8M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.7M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 10.6M +9.53M +867% Dec 31, 2020 10-K 2022-03-28
Q3 2020 1.12M Sep 30, 2020 10-Q 2020-11-16
Q4 2019 1.1M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.